Earnings on Tap: Abbott Laboratories
Despite notable progress in bringing down costs, the pharmaceuticals company still has plenty of room to increase profitability.
Global pharmaceuticals and health-care products company Abbott Laboratories (ABT) is slated to report its latest results before markets open Wednesday.
Earnings are expected to come in at $0.44 per share per Wall Street estimates, compared with $1.08 per diluted share reported in the year-ago period.
Gazala Parveen does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.